DURECT CORP (DRRX) - Insider Holders & Insider Ownership

List of insiders holdings for DURECT CORP:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1First Eagle Investment Management LLC
First Eagle Holdings Inc.
10% Owner		2019-09-04 17:50:090
26,476,546		26,476,546Form 4
2ASEN R SCOTT
10% Owner		2025-08-26 15:41:182,672,529
970,000		3,642,529Form 4
3SCHRECK THOMAS A
Chief Financial Officer		2005-02-17 20:14:143,022,450
0		3,022,450Form 13G
4JIAN LI
InterimPrincipalAccountingOfcr		2022-03-25 19:33:261,220,782
0		1,220,782Form 3
5Arenberg Michael
Chief Financial Officer		2022-01-10 17:49:05546,350
0		546,350Form 4
6NELSON TIMOTHY S
Sr. VP Business & Development		2004-12-21 20:47:05429,325
25,000		454,325Form 4
7THEEUWES FELIX
Chairman and CSO		2018-01-30 18:36:44279,428
0		279,428Form 4
8HOGAN MATTHEW J
Chief Financial Officer		2018-01-30 18:37:49278,910
0		278,910Form 4
9YUM SU IL
Exec. VP Pharm./R&D		2015-01-13 18:17:11221,024
0		221,024Form 4
10LIU JEAN I
Chief Legal Officer		2011-07-13 19:25:05184,627
0		184,627Form 4
11Mendenhall Paula V
Exec. VP of Operations/Admin.		2012-02-07 18:58:15156,810
0		156,810Form 4
12Stauffer Joseph William
CMO and Exec.VP Corp. Strategy		2011-01-21 18:51:52125,000
0		125,000Form 4
13BENITO SIMON X
Director		2021-12-09 13:35:14105,000
0		105,000Form 4
14GILLIS EDWARD M
VP Engineering		2004-03-02 18:31:35100,000
0		100,000Form 4
15Miksztal Andrew
VP Pharmaceutical R&D		2006-01-10 21:48:2975,000
0		75,000Form 4
16HALLADAY STEVEN
VP Clinical and Regulatory		2006-01-10 20:59:1572,000
0		72,000Form 4
17LANGECKER PETER
Chief Medical Officer		2009-05-26 14:58:0666,000
0		66,000Form 4
18HOFFMANN DAVE
Director		2022-06-17 16:10:4255,000
0		55,000Form 4
19Neukermans Armand
Director		2020-06-18 21:37:4155,000
0		55,000Form 4
20SAXE JON S
Director		2020-06-18 21:38:2955,000
0		55,000Form 4
21CHAN TAI WAH
VP Pharma. Research & Develp.		2005-11-08 21:14:5751,371
1000		52,371Form 4
22TIPTON ARTHUR J
Sr.VP Bioerodible Product Dev.		2004-03-02 18:35:4150,000
0		50,000Form 4
23Joice Judy R
Sr. VP Operations & Corp QA		2023-02-23 13:20:3437,456
0		37,456Form 4
24Shepard Jay
Director		2016-06-23 18:39:4635,000
0		35,000Form 4
25CASEY MICHAEL D
Director		2013-06-26 18:47:1935,000
0		35,000Form 4
26TAYLOR MICHAEL J
VP, Non Clinical Research		2004-04-02 20:51:1029,388
0		29,388Form 4/A
27Blaschke Terrence F
Director		2024-09-27 16:16:525,500
0		5,500Form 4
28First Eagle Investment Management LLC
21 APRIL FUND L.P.
21 APRIL FUND LTD.
First Eagle Value in Biotechnology Master Fund Ltd.
First Eagle Holdings Inc.
10% Owner		2019-09-04 17:27:470
0		0Form 13G
29Bleichroeder LP
10% Owner		2023-12-01 16:28:300
0		0Form 13G
30Papp Timothy M.
Chief Financial Officer		2025-09-12 20:14:160
0		0Form 4
31AZAB MOHAMMAD
Director		2025-09-12 20:17:010
0		0Form 4
32GARCIA PETER S
Director		2025-09-12 20:19:310
0		0Form 4
33Farfel Gail M
Director		2025-09-12 20:20:370
0		0Form 4
34Sussman Norman
Chief Medical Officer		2025-09-12 20:24:040
0		0Form 4
35Maderis Gail J
Director		2025-09-12 20:24:290
0		0Form 4
36Robertson Judith J.
Director		2025-09-12 21:34:050
0		0Form 4
37BROWN JAMES E
President & CEO		2025-09-16 14:16:300
0		0Form 4/A